The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella review

被引：2
|
作者：
Muoio, Barbara [1 ,2 ]
Albano, Domenico [3 ]
Dondi, Francesco [3 ]
Bertagna, Francesco [3 ]
Annunziata, Salvatore [4 ]
Fiz, Francesco [5 ]
Piccardo, Arnoldo [5 ]
Sadeghi, Ramin [6 ]
Treglia, Giorgio [7 ,8 ,9 ,10 ]
机构：
[1] Geneva Univ Hosp, Dept Oncol, Geneva, Switzerland
[2] Ente Osped Cantonale, Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[3] Univ Brescia, Dept Nucl Med, Spedali Civili Brescia, Brescia, Italy
[4] IRCCS A Gemelli Univ Polyclin Fdn, Dept Diagnost Imaging, Unit Nucl Med, Oncol Radiotherapy & Hematol, Rome, Italy
[5] EO Osped Galliera, Dept Nucl Med, Genoa, Italy
[6] Mashhad Univ Med Sci, Nucl Med Res Ctr, Mashhad, Iran
[7] Ente Osped Cantonale, Imaging Inst Southern Switzerland, Clin Nucl Med, Bellinzona, Switzerland
[8] Univ Lausanne, Lausanne Univ Hosp, Dept Nucl Med & Mol Imaging, Lausanne, Switzerland
[9] Univ Svizzera Italiana USi, Fac Biomed Sci, Lugano, Switzerland
[10] Ente Osped Cantonale, Imaging Inst Southern Switzerland, Clin Nucl Med, Via Gallino 12, CH-6500 Bellinzona, Switzerland
来源：
QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 66卷 / 03期
关键词：
Positron-emission tomography; Nuclear medicine; Multimodal imaging; Autoimmune diseases; RETROSPECTIVE ANALYSIS; SYSTEMATIC REVIEWS; TOMOGRAPHY;
D O I：
10.23736/S1824-4785.22.03456-2
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Paraneoplastic autoimmune disorders (PAD) are a group of autoimmune diseases associated with neoplasms. Several evidence-based articles (systematic reviews and meta-analyses) have reported data about the role of positron emission tomography (PET) and related hybrid modalities (e.g., PET/CT) using 2-deoxy-2-[18F]ftuoro-D-glucose ([18F]FDG) in patients with PAD. We performed an umbrella review of published sys-tematic reviews and meta-analyses in this setting to provide an evidence-based summary and suggestions for further studies. Several databases were searched to find systematic reviews and meta-analysis on [18F]FDG PET/CT in PAD. Evidence-based data support the use of [18F]FDG PET/CT in patients with suspected PAD for investigating an underlying malignancy even if it is still unclear whether [18F]FDG PET/CT should be performed after negative/inconclusive conventional imaging or as part of the initial workup of PAD.
引用
收藏
页码：229 / 233
页数：5
相关论文
共 50 条
  • [1] [18F]-fdg pet/ct in paraneoplastic osteoarthropathy
    Pauls, S.
    Krueger, S.
    Mottaghy, F. M.
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2007, 179 (01): : 80 - 82
  • [2] Role of FDG (18F) PET in paraneoplastic neurological syndromes
    Daragon, N.
    Desarnaud, S.
    Kas, A.
    Maksud, P.
    Houzard, C.
    Pina-Jomir, G.
    Farid, K.
    Abulizi, M.
    Habert, M. -O.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (07): : 399 - 405
  • [3] Robustness of radiomic features in [18F]-FDG PET/CT and [18F]-FDG PET/MR
    Vuong, D.
    Bogowicz, M.
    Huellner, M.
    Veit-Haibach, P.
    Andratschke, N.
    Unkelbach, J.
    Guckenberger, M.
    Tanadini-Lang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S41 - S41
  • [4] Staging with [18F]FDG PET/CT
    Iqbal, Ramsha
    Aras, Tuba
    Mammatas, Lemonitsa
    Vogel, Wouter V.
    Oprea-Lager, Daniela E.
    Verheul, Hendrik M.
    Boellaard, Ronald
    van Oordt, Catharina W. Menke-van der Houven
    CANCER RESEARCH, 2019, 79 (13)
  • [5] A Pictorial Review of 18F-FDG PET/CT for Paraneoplastic Syndromes
    O'Callaghan, C.
    O'Shea, C.
    Yates, J.
    Davies, S.
    Bartley, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S628 - S629
  • [6] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
    Vrachimis, Alexis
    Burg, Matthias Christian
    Wenning, Christian
    Allkemper, Thomas
    Weckesser, Matthias
    Schaefers, Michael
    Stegger, Lars
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (02) : 212 - 220
  • [7] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
    Alexis Vrachimis
    Matthias Christian Burg
    Christian Wenning
    Thomas Allkemper
    Matthias Weckesser
    Michael Schäfers
    Lars Stegger
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 212 - 220
  • [8] Robustness study on radiomic features in [18F]-FDG PET/CT and [18F]-FDG PET/MR
    Vuong, D.
    Bogowicz, M.
    Huellner, M.
    Veit-Haibach, P.
    Andratschke, N.
    Unkelbach, J.
    Guckenberger, M.
    Tanadini-Lang, S.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1159 - S1159
  • [9] Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR
    Diem Vuong
    Tanadini-Lang, Stephanie
    Huellner, Martin W.
    Veit-Haibach, Patrick
    Unkelbach, Jan
    Andratschke, Nicolaus
    Kraft, Johannes
    Guckenberger, Matthias
    Bogowicz, Marta
    MEDICAL PHYSICS, 2019, 46 (04) : 1677 - 1685
  • [10] [18F]FDG PET in hyperkinetic movement disorders: a systematic review
    Timmers, E.
    Klamer, M.
    Marapin, R.
    Lammertsma, A.
    De Jong, B.
    Dierckx, R.
    Tijssen, M.
    MOVEMENT DISORDERS, 2022, 37 : S39 - S39
12345